...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
【24h】

Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.

机译:手术N2非小细胞肺癌跳过淋巴结转移的危险因素及其预后价值

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The aim of this study is to report a series and to analyze risk factors for skip lymphatic metastasis an their prognostic value in operated N2 non-small-cell lung carcinoma. METHODS: From 1997 to 2002, 142 patients classified pN2 were included in the study. Tumours were classified according to the TNM classification. Skips metastases were defined by the cases of N2 disease without lobar and interlobar and hilar lymph node involvement. A skip (+) and a skip (-) group were defined. Characteristics of tumours, ganglionar involvement and survival were analysed in both groups. RESULTS: Forty-two patients fulfilled the criteria for skip metastasis. The average number of mediastinal lymph nodes resected by patient was similar in both groups, whereas more intrapulmonary nodes were dissected in the skip (-) group (4.7 +/- 3 vs 3 +/- 3; p < 0.002). The ratio of involved to resected lymph nodes was 0.47 +/- 0.27 in the skip (-) group vs 0.23 +/- 0.20 in the skip (+) group (p < 0.0001). In the skip (+)group, 85% of the patients presenting with a right upper lobe tumour had involvement of the superior mediastinal lymph nodes against 40% in the skip (-) group. The 5-year survival rate was 48% in the skip (-) group vs 37% in the skip (+) group (p = 0.49). In multivariate analysis, incomplete resection, tumour size, extended resection and pT were significant prognostic factors. CONCLUSIONS: Skip metastasis are frequent in non-small-cell lung cancer and complete dissection of hilar and mediastinal lymph nodes should remain the surgical standard procedure for this disease. However, skip metastasis are not an independent prognostic factor in survival.
机译:背景:本研究的目的是报告一系列数据并分析跳过淋巴结转移的危险因素及其在手术N2非小细胞肺癌中的预后价值。方法:从1997年到2002年,该研究共纳入142例分类为pN2的患者。根据TNM分类对肿瘤进行分类。跳过转移是由没有大叶,小叶间和肺门淋巴结受累的N2疾病病例定义的。定义了一个跳过(+)和一个跳过(-)组。两组均分析了肿瘤的特征,神经节累及和存活。结果:42例患者符合跳过转移的标准。两组患者平均切除的纵隔淋巴结平均数相似,而跳过(-)组的肺内淋巴结清扫更多(4.7 +/- 3 vs 3 +/- 3; p <0.002)。跳过(-)组的受累淋巴结与切除淋巴结的比率为0.47 +/- 0.27,而跳过(+)组为0.23 +/- 0.20(p <0.0001)。在跳过(+)组中,有右上叶肿瘤的患者中有85%的患者累及了上纵隔淋巴结,而在跳过(-)组中则为40%。跳过(-)组的5年生存率为48%,而跳过(+)组为37%(p = 0.49)。在多变量分析中,不完全切除,肿瘤大小,扩大切除和pT是重要的预后因素。结论:在非小细胞肺癌中,转移转移是经常发生的,肝门和纵隔淋巴结的完整解剖仍应是该疾病的手术标准程序。但是,跳过转移并不是生存的独立预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号